Phase Ib/IIa Trial to Evaluate Oregovomab and Nivolumab in Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin
Clinical trial NCT03100006 · TERMINATED
Trial details
- NCT number
- NCT03100006
- Sponsor
- National Cancer Centre, Singapore
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-22
- Primary completion
- 2019-06-07
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.